9 results
Real-world savings in medication-related costs up to 5 years with the use of the second-generation trabecular implant (iStent inject®) in mild open-angle glaucoma
226
Real-world evidence of the costs avoided over one year with the use of selective laser trabeculoplasty as a substitute therapy for eye drops
387
A Brazilian cost-utility analysis of trabecular micro-bypass with iStent inject® for the treatment of open-angle glaucoma
984
Estimating the cost of training an ophthalmologist in Brazil
2,567
Preventing glaucoma progression using the trabecular micro-bypass implant iStent inject®. A cost-effectiveness analysis
796
Financial impact on glaucoma surgical treatment
273
Cost analysis for ophthalmic clinics services
416
Phacoemulsification versus extracapsular extraction on public health care system: cost analysis to the hospital, to the government and to the society
181
1 2